[1]
“FORMULATION AND DEVELOPMENT OF STABLE METAXALONE NANOSUSPENSION USING 32 FACTORIAL DESIGN”, Int. J. Pharm. Sci. Drug Res., vol. 8, no. 4, pp. 223–228, Jul. 2016, doi: 10.25004/IJPSDR.2016.080406.